Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia
Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia
Not yet recruiting · NCT06793228 · Registry updated 2025-01-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia | SCLC, Extensive Stage | Not yet recruiting | Phase 2 | 2025-01-27 | NCT06793228 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Henan Cancer Hospital | 147 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henan cancer hospital, | Zhengzhou | China | 1 |
| The First Affiliated Hospital of Henan University of Science and Technolog | Luoyang | China | 1 |
| Xinxiang Central Hospital | Xinxiang | China | 1 |
| Zhengzhou Third People's Hospital" | Zhengzhou | China | 1 |